Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes

Three Ru(II)-based CO-releasing molecules featuring bidentate benzimidazole and terpyridine derivatives as ligands were investigated for their ability to modulate the aggregation process of the second helix of the C-terminal domain of nucleophosmin 1, namely nucleophosmin 1 (NPM1)<sub>264–277&...

Full description

Bibliographic Details
Main Authors: Daniele Florio, Maria Cuomo, Ilaria Iacobucci, Giarita Ferraro, Ahmed M. Mansour, Maria Monti, Antonello Merlino, Daniela Marasco
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/8/171
_version_ 1797560906719166464
author Daniele Florio
Maria Cuomo
Ilaria Iacobucci
Giarita Ferraro
Ahmed M. Mansour
Maria Monti
Antonello Merlino
Daniela Marasco
author_facet Daniele Florio
Maria Cuomo
Ilaria Iacobucci
Giarita Ferraro
Ahmed M. Mansour
Maria Monti
Antonello Merlino
Daniela Marasco
author_sort Daniele Florio
collection DOAJ
description Three Ru(II)-based CO-releasing molecules featuring bidentate benzimidazole and terpyridine derivatives as ligands were investigated for their ability to modulate the aggregation process of the second helix of the C-terminal domain of nucleophosmin 1, namely nucleophosmin 1 (NPM1)<sub>264–277</sub>, a model amyloidogenic system, before and after irradiation at 365 nm. Thioflavin T (ThT) binding assays and UV/Vis absorption spectra indicate that binding of the compounds to the peptide inhibits its aggregation and that the inhibitory effect increases upon irradiation (half maximal effective concentration (EC<sub>50</sub>) values in the high micromolar range). Electrospray ionization mass spectrometry data of the peptide in the presence of one of these compounds confirm that the modulation of amyloid aggregation relies on the formation of adducts obtained when the Ru compounds react with the peptide upon releasing of labile ligands, like chloride and carbon monoxide. This mechanism of action explains the subtle different behavior of the three compounds observed in ThT experiments. Overall, data support the hypothesis that metal-based CO releasing molecules can be used to develop metal-based drugs with potential application as anti-amyloidogenic agents.
first_indexed 2024-03-10T18:06:51Z
format Article
id doaj.art-3408f42cee084455b44555f64cf51d03
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T18:06:51Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-3408f42cee084455b44555f64cf51d032023-11-20T08:25:39ZengMDPI AGPharmaceuticals1424-82472020-07-0113817110.3390/ph13080171Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) ComplexesDaniele Florio0Maria Cuomo1Ilaria Iacobucci2Giarita Ferraro3Ahmed M. Mansour4Maria Monti5Antonello Merlino6Daniela Marasco7Department of Pharmacy, University of Naples Federico II, 80134 Napoli, ItalyDepartment of Pharmacy, University of Naples Federico II, 80134 Napoli, ItalyDepartment of Chemical Sciences, University of Naples Federico II, 80126 Napoli, ItalyDepartment of Chemistry Ugo Schiff, University of Florence, 50019 Sesto Fiorentino (FI), ItalyDepartment of Chemistry, Faculty of Science, University of Cairo, Gamma street, Giza 12613, EgyptDepartment of Chemical Sciences, University of Naples Federico II, 80126 Napoli, ItalyDepartment of Chemical Sciences, University of Naples Federico II, 80126 Napoli, ItalyDepartment of Pharmacy, University of Naples Federico II, 80134 Napoli, ItalyThree Ru(II)-based CO-releasing molecules featuring bidentate benzimidazole and terpyridine derivatives as ligands were investigated for their ability to modulate the aggregation process of the second helix of the C-terminal domain of nucleophosmin 1, namely nucleophosmin 1 (NPM1)<sub>264–277</sub>, a model amyloidogenic system, before and after irradiation at 365 nm. Thioflavin T (ThT) binding assays and UV/Vis absorption spectra indicate that binding of the compounds to the peptide inhibits its aggregation and that the inhibitory effect increases upon irradiation (half maximal effective concentration (EC<sub>50</sub>) values in the high micromolar range). Electrospray ionization mass spectrometry data of the peptide in the presence of one of these compounds confirm that the modulation of amyloid aggregation relies on the formation of adducts obtained when the Ru compounds react with the peptide upon releasing of labile ligands, like chloride and carbon monoxide. This mechanism of action explains the subtle different behavior of the three compounds observed in ThT experiments. Overall, data support the hypothesis that metal-based CO releasing molecules can be used to develop metal-based drugs with potential application as anti-amyloidogenic agents.https://www.mdpi.com/1424-8247/13/8/171modulators of amyloid peptide aggregationmetallodrugsruthenium(II) compoundsCO releasing molecules
spellingShingle Daniele Florio
Maria Cuomo
Ilaria Iacobucci
Giarita Ferraro
Ahmed M. Mansour
Maria Monti
Antonello Merlino
Daniela Marasco
Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
Pharmaceuticals
modulators of amyloid peptide aggregation
metallodrugs
ruthenium(II) compounds
CO releasing molecules
title Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
title_full Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
title_fullStr Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
title_full_unstemmed Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
title_short Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes
title_sort modulation of amyloidogenic peptide aggregation by photoactivatable co releasing ruthenium ii complexes
topic modulators of amyloid peptide aggregation
metallodrugs
ruthenium(II) compounds
CO releasing molecules
url https://www.mdpi.com/1424-8247/13/8/171
work_keys_str_mv AT danieleflorio modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT mariacuomo modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT ilariaiacobucci modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT giaritaferraro modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT ahmedmmansour modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT mariamonti modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT antonellomerlino modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes
AT danielamarasco modulationofamyloidogenicpeptideaggregationbyphotoactivatablecoreleasingrutheniumiicomplexes